Síndrome inflamatorio multisistémico por COVID-19

1 WHO. WHO coronavirus disease (COVID-19) dashboard. 2020. https://covid19.who.int (accessed Aug 5, 2020).

2 Government of Canada. Coronavirus disease 2019 (COVID-19): epidemiology update. https://health-infobase.canada.ca/covid-19/ epidemiological-summary-covid-19-cases.html (accessed July 16, 2020).

3 European Centre for Disease Prevention and Control. COVID-19. https://qap.ecdc.europa.eu/public/extensions/COVID-19/COVID-19. html (accessed June 19, 2020).

4 Epidemiology Working Group for NCIP Epidemic Response. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 145–51 (in Chinese).

5 Government of Pakistan. Pakistan cases details. http://covid.gov.pk/ stats/pakistan (accessed July 16, 2020).

6 WHO. Multisystem inflammatory syndrome in children and adolescents with COVID-19. https://www.who.int/publications/i/ item/multisystem-inflammatory-syndrome-in-children-andadolescents-with-covid-19 (accessed July 16, 2020).

7 Sanna G, Serrau G, Bassareo PP, Neroni P, Fanos V, Marcialis MA. Children’s heart and COVID-19: up-to-date evidence in the form of a systematic review. Eur J Pediatr 2020; 179: 1079–87.

8 Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 2020; 10: 537–40.

9 European Centre for Disease Prevention and Control. Rapid risk assessment: paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children. 2020. https://www.ecdc.europa.eu/ en/publications-data/paediatric-inflammatory-multisystemsyndrome-and-sars-cov-2-rapid-risk-assessment (accessed July 16, 2020). Search strategy and selection criteria References for this Review were identified through searches of PubMed for articles published from Jan 1, 1985, to July 7, 2020, using the Medical Subject Headings terms “SARS virus”, “coronavirus”, “systemic inflammatory response syndrome”, “mucocutaneous lymph node syndrome (Kawasaki disease)”, “infant, newborn”, “child”, “adolescent”, and any relevant entry terms and supplementary concepts. Relevant articles and data were also identified through searches in Google Scholar, WHO, Centers for Disease Control and Prevention, UK National Health Service, and other websites. Articles resulting from these searches and relevant references cited in those articles were reviewed. Articles published in English were identified and included.

10 Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395: 1607–08.

11 Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper-inflammatory syndrome in a child with COVID-19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr 2020; published online May 10. https://doi.org/10.1016/S0140-6736(20)31094-1.

12 Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395: 1771–78.

13 Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: prospective observational study. BMJ 2020; 369: m2094.

14 Rauf A, Vijayan A, John ST, Krishnan R, Latheef A. Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic. Indian J Pediatr 2020; published online May 22. https://doi.org/10.21203/rs.3.rs-29369/v1.

15 Chiotos K, Bassiri H, Behrens EM, et al. Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: a case series. J Pediatric Infect Dis Soc 2020; 9: 393–98.

16 Greene AG, Saleh M, Roseman E, Sinert R. Toxic shock-like syndrome and COVID-19: a case report of multisystem inflammatory syndrome in children (MIS-C). Am J Emerg Med 2020; published online June 6. https://doi.org/10.1016/j. ajem.2020.05.117.

17 Grimaud M, Starck J, Levy M, et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care 2020; 10: 69.

18 Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; published online June 8. https://doi.org/10.1001/jama.2020.10369.

19 Cheung EW, Zachariah P, Gorelik M, et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA 2020; published online June 8. https://doi.org/10.1001/jama.2020.10374.

20 Belhadjer Z, Méot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation 2020; published online May 17. https://doi.org/10.1161/CIRCULATIONAHA.120.048360.

21 Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in New York state. N Engl J Med 2020; 383: 347–58.

22 Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020; 383: 334–46.

23 Hameed S, Elbaaly H, Reid CEL, et al. Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. Radiology 2020;published online June 25. https://doi.org/10.1148/radiol.2020202543.

24 Kaushik S, Aydin SI, Derespina KR, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection: a multi-institutional study from New York City. J Pediatr 2020; published online June 13. https://doi.org/10.1016/j.jpeds.2020.06.045.

25 Capone CA, Subramony A, Sweberg T, et al. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS-CoV-2 infection. J Pediatr 2020; published online June 14. https://doi.org/10.1016/j. jpeds.2020.06.044.

26 Miller J, Cantor A, Zachariah P, Ahn D, Martinez M, Margolis K. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases. Gastroenterology 2020: published online June 4. https://doi. org/10.1053/j.gastro.2020.05.079.

27 Riollano-Cruz M, Akkoyun E, Briceno-Brito E, et al. Multisystem inflammatory syndrome in children (MIS-C) related to COVID-19: a New York City experience. J Med Virol 2020; published online June 25. https://doi.org/10.1002/jmv.26224.

28 Blondiaux E, Parisot P, Redheuil A, et al. Cardiac MRI of children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19: case series. Radiology 2020; published online June 9. https://doi.org/10.1148/radiol.2020202288.

29 Ng KF, Kothari T, Bandi S, et al. COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection. J Med Virol 2020; published online June 22. https://doi.org/10.1002/jmv.26206.

30 Ouldali N, Pouletty M, Mariani P, et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Health 2020; published online July 2. https://doi.org/10.1016/S2352-4642(20)30175-9.

31 Ramcharan T, Nolan O, Lai CY, et al. Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol 2020; published online June 12. https://doi.org/10.1007/s00246-020-02391-2.

32 Schupper AJ, Yaeger KA, Morgenstern PF. Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Childs Nerv Syst 2020; 36: 1579–80.

33 Pouletty M, Borocco C, Ouldali N, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis 2020; 79: 999–1006.

34 Rivera-Figueroa EI, Santos R, Simpson S, Garg P. Incomplete Kawasaki disease in a child with COVID-19. Indian Pediatr 2020; published online May 9. https://doi.org/10.1007/s13312-020-1900-0.

35 Waltuch T, Gill P, Zinns LE, et al. Features of COVID-19 postinfectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med 2020; published online May 23. https://doi.org/10.1016/j.ajem.2020.05.058.

36 Licciardi F, Pruccoli G, Denina M, et al. SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics 2020; published online July 28. https://doi.org/10.1542/peds.2020-1711.

37 Centers for Disease Control and Prevention. Multisystem inflammatory syndrome. 2020. https://www.cdc.gov/mis-c/hcp/ (accessed July 16, 2020).

38 Australian Government Department of Health. Australian Health Protection Principal Committee (AHPPC) coronavirus (COVID-19) statements on 14 May 2020. https://www.health.gov.au/news/ australian-health-protection-principal-committee-ahppccoronavirus-covid-19-statements-on-14-may-2020 (accessed July 16, 2020).

39 The Royal College of Paediatrics and Child Health. Guidance–paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS). 2020. https://www. rcpch.ac.uk/resources/guidance-paediatric-multisysteminflammatory-syndrome-temporally-associated-covid-19-pims (accessed July 16, 2020).

40 Levin M. Childhood multisystem inflammatory syndrome—a new challenge in the pandemic. N Engl J Med 2020; 383: 393–95.

41 Kanegaye JT, Wilder MS, Molkara D, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009; 123: e783–89.

42 Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747–71.

43 Gámez-González LB, Murata C, Muñoz-Ramírez M, Yamazaki-Nakashimada M. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Eur J Pediatr 2013; 172: 337–42.

44 Chen P-S, Chi H, Huang F-Y, Peng C-C, Chen M-R, Chiu N-C. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study. J Microbiol Immunol Infect 2015; 48: 43–50.

45 Lin Y-J, Cheng M-C, Lo M-H, Chien S-J. Early differentiation of Kawasaki disease shock syndrome and toxic shock syndrome in a pediatric intensive care unit. Pediatr Infect Dis J 2015; 34: 1163–67.

46 Yim D, Ramsay J, Kothari D, Burgner D. Coronary artery dilatation in toxic shock-like syndrome: the Kawasaki disease shock syndrome. Pediatr Cardiol 2010; 31: 1232–35.

47 Gamez-Gonzalez LB, Moribe-Quintero I, Cisneros-Castolo M, et al. Kawasaki disease shock syndrome: unique and severe subtype of Kawasaki disease. Pediatr Int (Roma) 2018; 60: 781–90.

48 Matsubara K, Fukaya T. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis 2007; 20: 298–303.

49 Gatterre P, Oualha M, Dupic L, et al. Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome. Intensive Care Med 2012; 38: 872–78.

50 Nagata S, Yamashiro Y, Ohtsuka Y, et al. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease. Immunology 2009; 128: 511–20.

51 Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020; 145: e20200702.

52 Liu Y, Yan L-M, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 2020; 20: 656–57.